Restasis and Entocort ec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Entocort ec (budesonide). Common drug interactions include urinary tract infection among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Entocort ec. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Entocort ec?

Entocort ec has active ingredients of budesonide. It is often used in crohn's disease. eHealthMe is studying from 3,232 Entocort ec users. Check the latest studies of Entocort ec.

On Jul, 31, 2026

20 people who take Restasis and Entocort ec together, and have interactions are studied.

Restasis and Entocort ec drug interactions.

What are the common drug interactions of Restasis and Entocort Ec, by gender? *:

female:

Urinary tract infection
Appetite disorder (abnormal eating habits)
Bone pain
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Muscular weakness (muscle weakness)
Osteoporosis (bones weak and more likely to break)
Vomiting
Contusion (a type of hematoma of tissue in which capillaries)

male:

Abdominal pain
Clostridial infection (infectious conditions by clostridium bacteria)
Diarrhoea
Infusion site reaction
Lung infection
Nausea (feeling of having an urge to vomit)
Vomiting
Oedema peripheral (superficial swelling)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the common drug interactions of Restasis and Entocort Ec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

30-39:

n/a

40-49:

n/a

50-59:

Anaphylactic reaction (serious allergic reaction)
Diarrhoea
Dyspepsia (indigestion)
Fungal infection
Injection site discolouration
Injection site erythema (redness at injection site)
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site haemorrhage (bleeding from injection site)
Injection site mass
Sinusitis (inflammation of sinus)

60+:

Nausea (feeling of having an urge to vomit)
Hip arthroplasty
Fall
Infusion site reaction
Joint swelling
Lung infection
Vomiting
Arthralgia (joint pain)
Disease recurrence
Dizziness

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 5 people, 25.00%
Pain: 4 people, 20.00%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 20.00%
Primary Immunodeficiency Syndrome: 3 people, 15.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%
Depression: 2 people, 10.00%
Insomnia (sleeplessness): 2 people, 10.00%
Urinary Tract Infection: 2 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
Diarrhea: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Entocort ec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously